Ted Ohashi
Contributor since: 2016
Latest Articles
Where We Are In The Cannabis Stock Market Cycle - An Update
Canadian Legalization: What's Next For Cannabis Stocks?
Sunniva: The Story Gets Better And Better
Sunniva: If You Like It, Buy It Now; If You Don't Like It, Buy It Now Anyway
Emerald Health And DMG Blockchain - A Perfect Match
Where We Are In The Cannabis Stock Market Cycle
Cannabis Stocks: Not A Dot-Com Bubble...Yet
Sunniva: Leading The World's Two Largest Legal Cannabis Markets
Canadian Cannabis Stocks: 2018 Outlook
How To Make Money On Cannabis Stocks In The Next Three Months
Canadian Cannabis Stocks: What To Do Now
How To Get Rich Quick: Rise Early, Work Late, Discover (Cannabis) Oil
September 18th Has Passed - Expect Canadian Cannabis Stocks To Rally Now
Health Canada Provincial Data Generates Investment Ideas
Latest Health Canada Report Is Good News For Licensed Producers
Expect An Upturn In Canadian Cannabis Stocks After September 18th
Stay In The Secular Bull Market For Cannabis Stocks
Organigram: Smooth Sailing Ahead
Emerald Health Therapeutics Transformational Transaction
Health Canada Data Confirms Industry Trends
Canadian Cannabis Stocks 2017 Outlook - Updated
Were IPO Investors Blindsided by Q$ Financials?
Is The MedReleaf IPO A Disaster Waiting To Happen?
Under The Cannabis Act - The Rich Get Richer
What The Cannabis Act Says And What It Means For Your Marijuana Stocks
Canadian Cannabis Companies Set To Advance On Legalization Legislation Next Week
Why Organigram Merits A 'Must Buy' Rating
How Attorney General Sessions Can Derail The Marijuana Gravy Train
How The Myclobutanil Recall Affects The Outlook For Canopy Growth And Organigram
Reassessing The Ever Changing Outlook For Canadian Cannabis Stocks
Update: My Confidence In Buying Organigram Is Affirmed
Canadian Cannabis Stocks: 2017 Outlook